Strong and specific expression was achieved in MTC cells due to the use of the modified calcitonin promoter used in our rAAV2 vectors, and continued expression of calcitonin in medullary carcinomas was confirmed [50, 51]. The gene discussed is CALCA; the disease is medullary thyroid gland carcinoma.